Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You may just get your wish. This stock has been making promises for years and now expects everyone to wait until 2025 for any hope of marketing its dry eye ointment, while looking for a partner to do the heavy lifting. Ahhhhhhh..........
PTN Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
https://finance.yahoo.com/news/palatin-announces-phase-3-pl9643-113000533.html
Well just great. Pump it the few days before the announcement and sell it on the news.
I love the way these low cap stocks move up and down on no news.
On the move with high volume. Hope something announced soon.
So I guess people are disappointed with the latest report. Nothing new but nothing detrimental either.
Did not see that coming. Why can’t they what. Til after the news
There are people here that seem to start buying 3 days before a big announcement but everybody is looking at before the end of the year will see
ANY SPECIFIC DATE ???
THANKS
Good luck in am. Need a new partner to launch eye sauce. Royalty payments with a down payment. New sex med, new Ibs med why are we at 2$
It was going a nice direction why fk it up.
Seems more like unloading today. Buy the rumor, sell the news.
Highest volume in over a year will take it. Money managers starting the load
It’s only up one buck a lot more money to be made
All time is around 1,670.00. A large Pharma should buy the stock and acquire it versus just paying for one or two of their drugs.
Last 3 days tells the story people loading the boat
Hw investors calling for 75$ I’ve seen that call once by them at it was right on rambus stock
Will take shorts 5 days to cover. Good run
Stock going to get out of the shitter soon should be 8$
They need to start looking for a marketing and sale partnership for eye product and Ibs product
Good loading day. Good news will come.
Maybe falls to floor tomorrow time to buy good luck to sll
It time for them to get in bed with a eye company and get some funding and royalty plans with them.
Nice move last few day. Congratulations to the faithful!
$PTN - Up 8% Pre-Market/ Current Price $2.44
Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
??31% growth over 2Q '23; 165% growth over 3Q '22
Yes there’s only like 11 million shares to this company and maybe 8 million warrants at higher prices. They have 3 good pipeline s of new drugs. First one will shoot it to 30 once nda gets approval. This one should be 8$ already with the low float. It will be bought and taken out buy a big eye company and the ulcerative colitis will be bought or co sold with Merck or another big boy wait and see
PTN Palatin Technologies, Inc.
Stock Split History (link goes to Seeking Alpha)
Date Ratio
Aug. 31, 2022 1:25
Sep. 27, 2010 1:10
Sep. 08, 1997 1:4
Jul. 22, 1996 1:10
The board has to get there shares before the company gets sold. Now set the price
I think we will see in next year no problem when products go to nda they will be bought buy a big guy or partners with ability to buy Ibs drug also that is where the stock will shoot the gap
Well at $8 I am ahead. $ 20 makes this a home run.
They also did a 20 for one stock split to shares trading at 10 cents it will go up fast with good news. Should be 8$ by now
Company’s future and products. If they start selling sex drug Europe then profits going up. But there pipeline is in stage 2 and 3 drugs with eye drug will be a good deal with all the old people in the USA. Those drugs are expensive any eye drops. They will partner up with some big company for there sales force and probably get a payment up front and royalties then the Ibs drug comes out of the pipe game on. HW a research company has company valued at 75$ a share.
Followers
|
177
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3712
|
Created
|
07/09/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |